Arterial Doppler Waveforms Analysis in PAD (APP-Wave-PAD)

Assessment of Professional Practices - Arterial Doppler Waveforms Analysis in PAD

The main objective is to evaluate the differences of terminology used when describing arterial doppler waveforms.

To assess the impact of an educational process

Study Overview

• Status: Unknown
• Conditions: French Vascular Physicians
• Intervention / Treatment: Other: Doppler arterial waveforms analysis

Detailed Description

Peripheral artery disease (PAD) is a common pathology that affects more than 200 million people worldwide. The prevalence of this pathology is estimated in France at 11% in patients over 40 years old. The Doppler arterial waveforms analysis is an important element to assess the hemodynamic state of a patient and contributes to the diagnosis of the pathology. A number of classifications have been proposed but their use varies from one university to another. We hypothesize that there is a great heterogeneity in the description of the arterial Doppler flow analysis. In addition, a new classification (Saint-Bonnet) has recently been proposed and we will evaluate the effect of the use of this one. The main objective is to evaluate the differences of terminology used when describing arterial Doppler waveforms.

The secondary objectives are: to understand the variations observed and expected (initial, continuous training, place of exercise ...) and to study the effect of a new classification on the heterogeneity of responses.

• Study Type: Observational
• Enrollment (Anticipated): 1000

Contacts and Locations

Study Locations

• France
  • Rennes, France, 35033
    • Centre Hospitalier Universitaire de Rennes

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (ADULT, OLDER_ADULT)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

Vascular physicians enrolled in the mailing list of French society of vascular medicine

Description

Inclusion Criteria:

• Vascular physicians enrolled in the mailing list of French society of vascular medicine

Exclusion Criteria:

• No exclusion criteria

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Differences of terminology	Number of different terminologies used by the vascular physicians to describe the arterial flows	through study completion, an average of 1 year

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Effect of a new classification on the heterogeneity of terminology used	Comparison of the number of terminology used without classification and the number of terminology used with a classification (Saint-Bonnet)	through study completion, an average of 1 year
Variations of description of the arterial Doppler waveforms	Significant difference in terms of heterogeneity by region or place of formation	through study completion, an average of 1 year

Collaborators and Investigators

• Sponsor: Rennes University Hospital
• Collaborators: French Society of Vascular Medicine
• Investigators: Principal Investigator: Guillaume MAHE, MD PHD, Rennes University Hospital

Study record dates

Study Major Dates

• Study Start (ACTUAL): December 1, 2018
• Primary Completion (ANTICIPATED): December 31, 2022
• Study Completion (ANTICIPATED): December 31, 2022

Study Registration Dates

• First Submitted: January 30, 2019
• First Submitted That Met QC Criteria: January 30, 2019
• First Posted (ACTUAL): February 1, 2019

Study Record Updates

• Last Update Posted (ACTUAL): July 18, 2019
• Last Update Submitted That Met QC Criteria: July 17, 2019
• Last Verified: July 1, 2019

More Information

Terms related to this study

• Keywords: Peripheral artery disease; classification; Vascular physicians; doppler waveforms; Saint-Bonnet
• Other Study ID Numbers: 35RC18_30019_APP-Wave-PAD

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No